In 2016 the first case of clinical vCJD in a 129 methionine/valine heterozygous (MV) individual was reported demonstrating that individuals with other genotypes were susceptible to vCJD and raising the possibility of a second wave of vCJD in individuals of this genotype (Mok et al., 2017).
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}